Medcura, Inc. — Form D
Medcura, Inc. of RIVERDALE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2025-07-25. The offering totals $38.3M, of which $28.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-07-25
- Form: D
- Accession: 0000929638-25-002712
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $38.3M
- Amount sold: $28.5M
- Remaining: $9.7M
- Investors: 174
- Date of first sale: 2025-04-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-552768
Issuer
- Name: Medcura, Inc.
- CIK: 0001672180
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5650 RIVERTECH COURT, SUITE S, RIVERDALE, MD, 20737
- Phone: 3014053585
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Abbas Ardehali, M.D. | Director | Riverdale, MD |
| Jim Buck | Director | Lakewood, WA |
| Matthew Dowling, Ph.D | Director | Riverdale, MD |
| Larry Tiffany | Director | Riverdale, MD |
| Jim Buck | Executive Officer | Lakewood, WA |
| Matthew Dowling, Ph.D | Executive Officer | Riverdale, MD |
| Larry Tiffany | Executive Officer | Riverdale, MD |
| Rich Vincent | Executive Officer | Riverdale, MD |
| Matthew Dowling | Director | Riverdale, MD |
| Matthew Dowling | Executive Officer | Riverdale, MD |
| Alex Arrow | Director | Riverdale, MD |
| Peter Thomas | Director | Columbus, OH |
| Peter Thomas | Executive Officer | Columbus, OH |
Other filings by this issuer (8)
More